{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:12:27Z","timestamp":1791911547133,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.steroids.2011.12.002","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T21:02:27Z","timestamp":1323896547000},"page":"295-299","source":"Crossref","is-referenced-by-count":97,"title":["Dyslipidemia in PCOS"],"prefix":"10.1016","volume":"77","author":[{"given":"Robert A.","family":"Wild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.steroids.2011.12.002_b0005","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.steroids.2011.12.002_b0010","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diabetes.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.steroids.2011.12.002_b0015","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-61-5-946","article-title":"Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome","volume":"61","author":"Wild","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.steroids.2011.12.002_b0020","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Dyslipidemia in PCOS: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.steroids.2011.12.002_b0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0002-9378(88)80099-1","article-title":"The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome","volume":"159","author":"Wild","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.steroids.2011.12.002_b0030","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0002-9378(11)90605-X","article-title":"Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance","volume":"166","author":"Wild","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.steroids.2011.12.002_b0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.fertnstert.2009.03.005","article-title":"Can serum apolipoprotein C\u2013I demonstrate metabolic abnormality early in women with polycystic ovary syndrome?","volume":"94","author":"Huang","year":"2010","journal-title":"Fertil Steril"},{"issue":"9438","key":"10.1016\/j.steroids.2011.12.002_b0040","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case\u2013control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.steroids.2011.12.002_b0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/CS20090402","article-title":"Regulation of plasma LDL: the apoB paradigm","volume":"118","author":"Sniderman","year":"2010","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"10.1016\/j.steroids.2011.12.002_b0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/MOL.0b013e32833ee80c","article-title":"Non-HDL C equals apolipoprotein B: except when it does not!","volume":"21","author":"Sniderman","year":"2010","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"10.1016\/j.steroids.2011.12.002_b0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.steroids.2011.12.002_b0060","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/ATVBAHA.110.221846","article-title":"Apolipoprotein CIII: 42years old and even more interesting","volume":"31","author":"Ginsberg","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.steroids.2011.12.002_b0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2265.2001.01228.x","article-title":"Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters","volume":"54","author":"Pirwany","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.steroids.2011.12.002_b0070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jc.2006-1705","article-title":"Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome","volume":"92","author":"Berneis","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.steroids.2011.12.002_b0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ajog.2007.09.014","article-title":"How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?","volume":"198","author":"Rizzo","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.steroids.2011.12.002_b0080","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jc.2007-1756","article-title":"A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case\u2013control study","volume":"93","author":"Valkenburg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.steroids.2011.12.002_b0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1447-0756.2007.00685.x","article-title":"Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria","volume":"34","author":"Bhattacharya","year":"2008","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.steroids.2011.12.002_b0110","unstructured":"Meyer ML, Malek AM, Wild RA, Korytkowski MT, Talbott EO. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update, in press."},{"issue":"15","key":"10.1016\/j.steroids.2011.12.002_b0090","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/01.CIR.0000161801.65408.8D","article-title":"Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women","volume":"111","author":"Tanko","year":"2005","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.steroids.2011.12.002_b0095","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000033222.75187.B9","article-title":"Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women","volume":"106","author":"Blake","year":"2002","journal-title":"Circulation"},{"issue":"9298","key":"10.1016\/j.steroids.2011.12.002_b0100","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(01)07098-2","article-title":"High apolipoprotein B, low apolipoprotein A\u2013I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study","volume":"358","author":"Walldius","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.steroids.2011.12.002_b0105","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE\u2013PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11003473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11003473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T18:22:10Z","timestamp":1713205330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X11003473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0039128X11003473"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2011.12.002","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}